A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma (original) (raw)
Asahara T, Itamoto T, Katayama K et al (1999) Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma–results of long-term follow-up. Hepatogastroenterology 46:1042–1048 CASPubMed Google Scholar
Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430. doi:10.1016/S0168-8278(01)00130-1 ArticleCASPubMed Google Scholar
Chen XP, Huang ZY (2005) Surgical treatment of hepatocellular carcinoma in China: surgical techniques, indications, and outcomes. Langenbecks Arch Surg 390:259–265. doi:10.1007/s00423-005-0552-9 ArticlePubMed Google Scholar
Cheng HY, Wang X, Chen D et al (2005) The value and limitation of transcatheter arterial chemoembolization in preventing recurrence of resected hepatocellular carcinoma. World J Gastroenterol 11:3644–3646 PubMed Google Scholar
Edwards BK, Brown ML, Wingo PA et al (2005) Annual report to the nation on the status of cancer 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97:1407–1427 ArticlePubMed Google Scholar
Fan J, Zhou J, Wu ZQ et al (2005) Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 11:1215–1219 PubMed Google Scholar
Fattovich G, Stroffolini T, Zagni I et al (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127(suppl):35–50. doi:10.1053/j.gastro.2004.09.014 Article Google Scholar
Guo RP, Chen MS, Lin XJ et al (2000) Significance of removing portal vein thrombus and TACE in improving outcome of resection for primary liver cancer with portal vein tumor thrombus. Chin J Hepatobiliary Surg 6:374–376 Google Scholar
Guo RP, Zhong C, Shi M et al (2006) Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma. J Cancer Res Clin Oncol 132:547–555. doi:10.1007/s00432-006-0097-5 ArticleCASPubMed Google Scholar
Hasegawa K, Takayama T, Ijichi M, Matsuyama Y et al (2006) Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. Hepatology 44:891–895. doi:10.1002/hep.21341 ArticleCASPubMed Google Scholar
Ikai I, Arii S, Kojiro M et al (2004) Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 101:796–802. doi:10.1002/cncr.20426 ArticlePubMed Google Scholar
Ikeda K, Arase Y, Saitoh S et al (2000) Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 32:228–232. doi:10.1053/jhep.2000.9409 ArticleCASPubMed Google Scholar
International Union Against Cancer (UICC) (2002) In: Sobin LH, Wittekind C (eds) TNM classification of malignant tumors, 6th edn. Wiley, New York, pp 81–83
Izumi R, Shimizu K, Iyobe T et al (1994) Postoperative adjuvant arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology 20:295–301 ArticleCASPubMed Google Scholar
Kubo S, Nishiguchi S, Hirohashi K et al (2001) Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann Intern Med 134:963–967 CASPubMed Google Scholar
Kumada K, Ozawa K, Okamoto R et al (1990) Hepatic resection for advanced hepatocellular carcinoma with removal of portal vein tumor thrombi. Surgery 108:821–827 CASPubMed Google Scholar
Kwok PC, Lam TW, Lam PW et al (2003) Randomized controlled trial to compare the dose of adjuvant chemotherapy after curative resection of hepatocellular carcinoma. J Gastroenterol Hepatol 18:450–455. doi:10.1046/j.1440-1746.2003.03015.x ArticleCASPubMed Google Scholar
Lau WY, Leung TW, Ho SK et al (1999) Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 353:797–801. doi:10.1016/S0140-6736(98)06475-7 ArticleCASPubMed Google Scholar
Lau WY, Lai EC, Leung TW et al (2008) Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival. Ann Surg 247:43–48 ArticlePubMed Google Scholar
Le Treut YP, Hardwigsen J, Ananian P et al (2006) Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series. J Gastrointest Surg 10:855–862. doi:10.1016/j.gassur.2005.12.011 ArticlePubMed Google Scholar
Li JQ, Zhang YQ, Zhang WZ et al (1995) Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy. J Cancer Res Clin Oncol 121:364–366. doi:10.1007/BF01225689 ArticleCASPubMed Google Scholar
Li BK, Cui BK, Yuan YF et al (2005) Evaluation of new TNM staging system for hepatocellular carcinoma after hepatectomy. Ai Zheng 24:769–773 PubMed Google Scholar
Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment. Ann Surg 211:277–287 Google Scholar
Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429–442. doi:10.1053/jhep.2003.50047 ArticleCASPubMed Google Scholar
Lopez PM, Villanueva A, Llovet JM (2006) Systematic review: evidence-based management of hepatocellular carcinoma-an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 23:1535–1547. doi:10.1111/j.1365-2036.2006.02932.x ArticleCASPubMed Google Scholar
Mondazzi L, Bottelli R, Brambilla G et al (1994) Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 19:1115–1123 ArticleCASPubMed Google Scholar
Ng KK, Vauthey JN, Pawlik TM et al (2005) Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 12:364–373. doi:10.1245/ASO.2005.06.004 ArticlePubMed Google Scholar
Poon RT, Fan ST, Lo CM et al (1999) Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229:216–222. doi:10.1097/00000658-199902000-00009 ArticleCASPubMed Google Scholar
Poon RT, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232:10–24. doi:10.1097/00000658-200007000-00003 Article Google Scholar
Ren ZG, Lin ZY, Xia JL et al (2004) Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective controlled study. World J Gastroenterol 10:2791–2794 PubMed Google Scholar
Roayaie S, Frischer JS, Emre SH et al (2002) Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 235:533–539. doi:10.1097/00000658-200204000-00012 ArticlePubMed Google Scholar
Shi M, Guo RP, Lin XJ et al (2007) Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 245:36–43. doi:10.1097/01.sla.0000231758.07868.71 ArticlePubMed Google Scholar
Tanaka S, Shimada M, Shirabe K et al (2005) A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma. Hepatogastroenterology 52:862–865 PubMed Google Scholar